Virtual reality firm focused on the education sector,, announced on Thursday the roll-out of its ENGAGE platform with medical training app, Life-saving Instruction for Emergencies.
Developed with Oxford University, HTC, and the KEMRI-Welcome Trust Research Programme, LIFE will launch the platform today with VR Education at the Council of International Neonatal Nurses conference in Nairobi, Kenya.
The app benefits healthcare workers by allowing them to deal with virtual patients via their smartphone or headset -- the group believes the app could “dramatically improve outcomes” in low-resource areas where access to simulation training is limited or expensive.
"Operating via our versatile ENGAGE platform, LIFE has been designed to provide healthcare workers with universal access to high quality medical education and offers the potential to dramatically promote access to life-saving knowledge in developing nations,” said David Whelan, CEO of VR Education.
The LIFE smartphone app is now being rolled out across Kenya through partnerships with medical and nursing schools and professional organisations such as the Kenya Paediatric Association.
“Supporting LIFE on a pro bono basis will increase awareness of our ENGAGE platform with medical professionals and students which we are confident will lead to enquiries from medical trainers seeking to host their own applications on the ENGAGE platform on a paid basis," Mr Whelan further commented.
“By using immersive VR simulation training in combination with a personal smartphone app, the LIFE project has the potential to support healthcare worker training at scale,” added Dr Chris Paton, the lead researcher for LIFE from the University of Oxford.
Follow News & Updates from VR Education here:
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
Majid Shafiq, CEO of i3 Energy (AIM:I3E), and CFO, Graham Heath, discuss today’s follow-on deal to sell the Gain assets to Harvard Resources which will occur following the completion of the group’s previously announced C$80 million reverse takeover .
i3 Energy plc, an independent oil and gas company with assets and operations in the UK, Final Results for the year ended 31 December 2019 show significant operational progress for the pre-revenue company with net loss of £10.8m. To fund the Gain acquisition announced post period end in 2020, i3 is proposing to raise £30 million at a price of 5 pence per share, an 18% discount to the closing mid-price at which i3's shares suspended on 23 June 2020.
Oilex, the Operator of the PSC and on behalf of the JDPA joint venture, has reached amicable settlement with JPDA in East Timor with a settlement of US$0.8m payable in 2021 and 2022 financial years. The settlement amount is fully provided for in the FY19 accounts.
Avacta Group has entered into a collaboration with the Liverpool School of Tropical Medicine to clinically validate the rapid, saliva-based coronavirus antigen test that Avacta is developing in conjunction with Cytiva.
Shield Therapeutics said a reanalysis of the AEGIS-H2H study for its iron deficiency lead product Feraccru®/Accrufer® has confirmed the product as a credible alternative to IV therapy for patients with iron deficiency anaemia.